Several calcium (Ca2+) channel blockers show anti-calmodulin activity, inhibiting key enzymes like Ca2+-ATPase. Binding studies reveal differential drug interactions with calmodulin halves, impacting drug development for calmodulin-related conditions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: